![Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/fec1e2e8-1746-4367-ab4d-0b1d79098e29/jdv17623-fig-0001-m.jpg)
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology
![Efficacy and safety of oral minoxidil in female androgenetic alopecia - Vastarella - 2020 - Dermatologic Therapy - Wiley Online Library Efficacy and safety of oral minoxidil in female androgenetic alopecia - Vastarella - 2020 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/05517b08-a523-49f1-bf39-8ed758a89b7c/dth14234-fig-0001-m.jpg)
Efficacy and safety of oral minoxidil in female androgenetic alopecia - Vastarella - 2020 - Dermatologic Therapy - Wiley Online Library
![Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia - Journal of the American Academy of Dermatology Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia - Journal of the American Academy of Dermatology](https://www.jaad.org/cms/asset/07098294-2225-4640-ac45-0942343f0306/gr1.jpg)
Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia - Journal of the American Academy of Dermatology
![PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment](https://i1.rgstatic.net/publication/344384491_Efficacy_and_Safety_of_Oral_Minoxidil_5_mg_Once_Daily_in_the_Treatment_of_Male_Patients_with_Androgenetic_Alopecia_An_Open-Label_and_Global_Photographic_Assessment/links/600cfcc445851553a0679a57/largepreview.png)
PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
![Combination therapy with oral minoxidil and dutasteride in the treatment of male patterned baldness: A case report - Cosmoderma Combination therapy with oral minoxidil and dutasteride in the treatment of male patterned baldness: A case report - Cosmoderma](https://cosmoderma.org/content/130/2022/2/1/img/CSDM-2-4-g002.png)
Combination therapy with oral minoxidil and dutasteride in the treatment of male patterned baldness: A case report - Cosmoderma
![JCM | Free Full-Text | Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects JCM | Free Full-Text | Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects](https://www.mdpi.com/jcm/jcm-10-04257/article_deploy/html/images/jcm-10-04257-g001.png)